These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 32025679)
21. Stereoselective synthesis of 2-deoxy-beta-galactosides via 2-deoxy-2-bromo- and 2-deoxy-2-iodo-galactopyranosyl donors. Durham TB; Roush WR Org Lett; 2003 May; 5(11):1871-4. PubMed ID: 12762674 [TBL] [Abstract][Full Text] [Related]
22. Fluorine-directed β-galactosylation: chemical glycosylation development by molecular editing. Durantie E; Bucher C; Gilmour R Chemistry; 2012 Jun; 18(26):8208-15. PubMed ID: 22592962 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and preliminary bioactivity assays of 3,4-dichloro-5-(omega-hydroxyalkylamino)-2(5H)-furanones. Gondela E; Walczak KZ Eur J Med Chem; 2010 Sep; 45(9):3993-7. PubMed ID: 20573426 [TBL] [Abstract][Full Text] [Related]
24. Triclosan-caffeic acid hybrids: Synthesis, leishmanicidal, trypanocidal and cytotoxic activities. Otero E; García E; Palacios G; Yepes LM; Carda M; Agut R; Vélez ID; Cardona WI; Robledo SM Eur J Med Chem; 2017 Dec; 141():73-83. PubMed ID: 29028533 [TBL] [Abstract][Full Text] [Related]
25. A comprehensive review of chalcone derivatives as antileishmanial agents. de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038 [TBL] [Abstract][Full Text] [Related]
26. Antileishmanial activities of dihydrochalcones from piper elongatum and synthetic related compounds. Structural requirements for activity. Hermoso A; Jiménez IA; Mamani ZA; Bazzocchi IL; Piñero JE; Ravelo AG; Valladares B Bioorg Med Chem; 2003 Sep; 11(18):3975-80. PubMed ID: 12927858 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of S- and C-galactofuranosides via a galactofuranosyl iodide. Isolable 1-galactofuranosylthiol derivative as a new glycosyl donor. Baldoni L; Marino C Carbohydr Res; 2012 Nov; 362():70-8. PubMed ID: 23089145 [TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationship of antileishmanials neolignan analogues. Aveniente M; Pinto EF; Santos LS; Rossi-Bergmann B; Barata LE Bioorg Med Chem; 2007 Dec; 15(23):7337-43. PubMed ID: 17888668 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and antiprotozoal activity of naphthofuranquinones and naphthothiophenequinones containing a fused thiazole ring. Tapia RA; Alegria L; Pessoa CD; Salas C; Cortés MJ; Valderrama JA; Sarciron ME; Pautet F; Walchshofer N; Fillion H Bioorg Med Chem; 2003 May; 11(10):2175-82. PubMed ID: 12713827 [TBL] [Abstract][Full Text] [Related]
30. A fluorometric method for evaluation of pharmacological activity against intracellular Leishmania amastigotes. Bilbao-Ramos P; Sifontes-Rodríguez S; Dea-Ayuela MA; Bolás-Fernández F J Microbiol Methods; 2012 Apr; 89(1):8-11. PubMed ID: 22310031 [TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold. Staderini M; Piquero M; Abengózar MÁ; Nachér-Vázquez M; Romanelli G; López-Alvarado P; Rivas L; Bolognesi ML; Menéndez JC Eur J Med Chem; 2019 Jun; 171():38-53. PubMed ID: 30904756 [TBL] [Abstract][Full Text] [Related]
32. Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine. Chibale K; Haupt H; Kendrick H; Yardley V; Saravanamuthu A; Fairlamb AH; Croft SL Bioorg Med Chem Lett; 2001 Oct; 11(19):2655-7. PubMed ID: 11551771 [TBL] [Abstract][Full Text] [Related]
33. In vitro leishmanicidal activity of benzophenanthridine alkaloids from Bocconia pearcei and related compounds. Fuchino H; Kawano M; Mori-Yasumoto K; Sekita S; Satake M; Ishikawa T; Kiuchi F; Kawahara N Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1047-50. PubMed ID: 20686258 [TBL] [Abstract][Full Text] [Related]
34. Leishmanicidal activity of some stilbenoids and related heterocyclic compounds. del Olmo E; Armas MG; López-Pérez JL; Muñoz V; Deharo E; San Feliciano A Bioorg Med Chem Lett; 2001 Aug; 11(16):2123-6. PubMed ID: 11514152 [TBL] [Abstract][Full Text] [Related]
36. Computational Identification of Chemical Compounds with Potential Activity against Leishmania amazonensis using Nonlinear Machine Learning Techniques. Castillo-Garit JA; Flores-Balmaseda N; Álvarez O; Pham-The H; Pérez-Doñate V; Torrens F; Pérez-Giménez F Curr Top Med Chem; 2018; 18(27):2347-2354. PubMed ID: 30499402 [TBL] [Abstract][Full Text] [Related]
37. Discovery of synthetic Leishmania inhibitors by screening of a 2-arylbenzothiophene library. Bonano VI; Yokoyama-Yasunaka JK; Miguel DC; Jones SA; Dodge JA; Uliana SR Chem Biol Drug Des; 2014 Mar; 83(3):289-96. PubMed ID: 24119198 [TBL] [Abstract][Full Text] [Related]
38. β-Sitosterol from Ifloga spicata (Forssk.) Sch. Bip. as potential anti-leishmanial agent against leishmania tropica: Docking and molecular insights. Majid Shah S; Ullah F; Ayaz M; Sadiq A; Hussain S; Ali Shah AU; Adnan Ali Shah S; Wadood A; Nadhman A Steroids; 2019 Aug; 148():56-62. PubMed ID: 31085212 [TBL] [Abstract][Full Text] [Related]
40. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis. Rosypal AC; Werbovetz KA; Salem M; Stephens CE; Kumar A; Boykin DW; Hall JE; Tidwell RR J Parasitol; 2008 Jun; 94(3):743-9. PubMed ID: 18605790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]